Titan Biotech Limited

BSE:524717 Stock Report

Market Cap: ₹16.4b

Titan Biotech Management

Management criteria checks 4/4

Titan Biotech's CEO is Naresh Singla, appointed in Apr 2018, has a tenure of 8.17 years. total yearly compensation is ₹4.80M, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 0.54% of the company’s shares, worth ₹88.36M. The average tenure of the management team and the board of directors is 6.8 years and 3.7 years respectively.

Key information

Naresh Singla

Chief executive officer

₹4.8m

Total compensation

CEO salary percentage100.00%
CEO tenure8.2yrs
CEO ownership0.5%
Management average tenure6.8yrs
Board average tenure3.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Naresh Singla's remuneration changed compared to Titan Biotech's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2026n/an/a

₹299m

Dec 31 2025n/an/a

₹272m

Sep 30 2025n/an/a

₹231m

Jun 30 2025n/an/a

₹220m

Mar 31 2025₹5m₹5m

₹215m

Dec 31 2024n/an/a

₹225m

Sep 30 2024n/an/a

₹253m

Jun 30 2024n/an/a

₹251m

Mar 31 2024₹5m₹5m

₹249m

Dec 31 2023n/an/a

₹248m

Sep 30 2023n/an/a

₹209m

Jun 30 2023n/an/a

₹227m

Mar 31 2023₹5m₹5m

₹248m

Dec 31 2022n/an/a

₹249m

Sep 30 2022n/an/a

₹268m

Jun 30 2022n/an/a

₹249m

Mar 31 2022₹5m₹5m

₹217m

Dec 31 2021n/an/a

₹241m

Sep 30 2021n/an/a

₹255m

Jun 30 2021n/an/a

₹263m

Mar 31 2021₹5m₹5m

₹303m

Dec 31 2020n/an/a

₹285m

Sep 30 2020n/an/a

₹236m

Jun 30 2020n/an/a

₹178m

Mar 31 2020₹5m₹5m

₹71m

Compensation vs Market: Naresh's total compensation ($USD50.90K) is below average for companies of similar size in the Indian market ($USD173.34K).

Compensation vs Earnings: Naresh's compensation has been consistent with company performance over the past year.

CEO

Naresh Singla (67 yo)

8.2yrs
Tenure
₹4,800,000
Compensation

Mr. Naresh Kumar Singla serves as Managing Director of Titan Biotech Limited since April 1, 2018 and its Director since February 18, 1992. Mr. Singla joined the Titan Biotech Limited on February 18, 1992....

Leadership Team

NamePositionTenureCompensationOwnership
Naresh Singla
MD & Executive Director8.2yrs₹4.80m0.54%
₹ 88.4m
Suresh Singla
MD & Executive Director8.2yrs₹4.80m1.28%
₹ 209.8m
Prem Gupta
Chief Financial Officerno data₹1.74mno data
Charanjit Singh
Company Secretaryno data₹2.20mno data
Raja Singla
Senior VP of Production & Whole Time Executive Director6.8yrs₹12.00m0.74%
₹ 121.3m
Udit Singla
Whole Time Executive Director2.7yrs₹12.00m0.61%
₹ 99.3m
Shivom Singla
Whole Time Executive Director2.7yrs₹12.00m0.43%
₹ 70.3m
Madhu Singla
Vice President of Admn.no datano datano data
6.8yrs
Average Tenure
37yo
Average Age

Experienced Management: 524717's management team is seasoned and experienced (6.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Naresh Singla
MD & Executive Director34.3yrs₹4.80m0.54%
₹ 88.4m
Suresh Singla
MD & Executive Director34.3yrs₹4.80m1.28%
₹ 209.8m
Raja Singla
Senior VP of Production & Whole Time Executive Director3.7yrs₹12.00m0.74%
₹ 121.3m
Udit Singla
Whole Time Executive Director2.7yrs₹12.00m0.61%
₹ 99.3m
Shivom Singla
Whole Time Executive Director2.7yrs₹12.00m0.43%
₹ 70.3m
Manju Singla
Non-Executive Woman Director25yrsno data0.86%
₹ 141.4m
Supriya Singla
Non-Executive Non-Independent Director13.7yrsno data0.66%
₹ 108.2m
Rohit Jain
Non-Executive Independent Chairman4.9yrsno datano data
Abhishek Agarwal
Independent Non-Executive Director3.7yrs₹84.00kno data
Dhairya Madan
Independent Non-executive Director2.7yrs₹82.00kno data
Brijesh Singh
Independent Non-executive Director2.7yrs₹77.00kno data
Debendra Sabat
Independent Non-Executive Directorless than a yearno datano data
3.7yrs
Average Tenure
37yo
Average Age

Experienced Board: 524717's board of directors are considered experienced (3.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/28 06:04
End of Day Share Price 2026/06/25 00:00
Earnings2026/03/31
Annual Earnings2026/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Titan Biotech Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.